Liquid biopsy identifies mutations in colorectal cancer undetected in tissue biopsy
An international, randomized, phase III study has analyzed the DNA of 503 patients with metastatic colorectal cancer by liquid biopsy (BEAMing platform) to detect KRAS, PIK3CA and BRAF gene mutations in tumors. These patients, ...
Jul 13, 2015